Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Bacterial DNA synthesis is the process by which anaerobic bacteria replicate their genetic material, enabling cell division and propagation. This process is essential for bacterial survival and growth, making it a critical target for antibacterial agents. The fundamental mechanisms of DNA replication are similar to those in aerobic bacteria but can be influenced by the unique metabolic conditions present under anaerobic growth. Targeting bacterial DNA synthesis is highly effective because it disrupts an essential cellular process required for proliferation. Resistance can develop through mutations in target enzymes or altered drug uptake.
Inhibition of DNA gyrase/topoisomerase IV (Fluoroquinolones); DNA damage via toxic intermediates (Metronidazole)
1 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Bacterial DNA Synthesis (Anaerobes).